관리자

03/05/2019

IVI receives $3.2 million grant to support TCV effectiveness studies in West Africa

  SEOUL, Korea — The International Vaccine Institute (IVI) has been awarded a $3,238,974 grant from the Bill & Melinda Gates Foundation to provide technical assistance support for studies to measure the effectiveness of typhoid conjugate vaccine (TCV) in West Africa. This grant comes after […]
02/11/2019

CEPI partners with IVI to accelerate development of vaccines against emerging global health threats

– Bilateral ‘Master Implementing Partner Services Agreement’ expected to enable IVI to provide technical capabilities to CEPI   Oslo, Norway; Seoul, Republic of Korea 11 February 2019—The Coalition for Epidemic Preparedness Innovations (CEPI) and the Republic of Korea-based International Vaccine Institute (IVI), an international organisation […]
01/09/2019

Henry Lau joins IVI as Goodwill Ambassador

– Singer-songwriter, Henry to team up with the International Vaccine Institute (IVI), founded by the United Nations Development Programme to develop and deliver new vaccines for global health – IVI Director General Dr. Jerome Kim: “IVI is privileged to have Henry on board, and grateful […]
12/12/2018

Nature Communications study addresses MDR typhoid

New study in Nature Communications reveals high burden of multi-drug resistant (MDR) typhoid fever in sub-Saharan Africa associated with two predominant genotypes – IVI epidemiologist Se Eun Park and collaborating scientists report data from Typhoid Fever Surveillance in Africa (TSAP) program and other sources   […]